Sponsored Symposium

October 15, Thursday

Sponsored Symposium 1 - Astellas Pharma Korea, Inc.
Management Paradigms for Castration-Resistant Prostate Cancer
Online Channel 1
Chairperson(s)
Jun Hyuk Hong (Korea)
12:00-12:30
Improving Outcomes through Optimal Treatment Strategies for Patients with Castration-Resistant Prostate Cancer Bertrand Tombal (Belgium)
12:30-13:00
Practical Experience in Castration-Resistant Prostate Cancer Patients during the COVID-19 Pandemic Era Nicolas Mottet (France)

October 16, Friday

Sponsored Symposium 2 - Astellas Pharma Korea, Inc.
OAB
Online Channel 1
Chairperson(s)
Jong Bo Choi (Korea)
12:00-13:00
Optimising OAB Pharmacological Treatment: a Patient-Centric Approach Sender Herschorn (Canada)
Sponsored Symposium 3 - Janssen Korea Ltd.
Prostate Cancer
Online Channel 2
Chairperson(s)
Choung Soo Kim (Korea)
12:00-12:30
The Critical Need of Delaying mCRPC from nmCRPC: Current and Future Treatment Options for nmCRP Jae Young Joung (Korea)
Sponsored Symposium 4 - GSK (GlaxoSmithKline)
Online Channel 2
12:30-13:00
Efficacy and Safety Perspectives of 5ARI (Duta vs Fina) for LUTS/BPH Juan Manuel Palacios Moreno (Spain)
Sponsored Symposium 5 - OLYMPUS KOREA CO., LTD.
NBI
Online Channel 2
15:00-15:30
Clinical Benefits of Narrow Band Imaging (NBI) Cystoscopy and TURBT in Non-muscle Invasive Bladder Cancer Seock Hwan Choi (Korea)
Sponsored Symposium 6 - OLYMPUS KOREA CO., LTD.
Shock Pulse
Online Channel 1
17:00-17:30
Experience of Using Stone Eliminator, Shock Pulse Hyeon Woo Kim (Korea)
Sponsored Symposium 7 - Amgen Korea
Online Channel 1
17:30-18:00
Recent Updates in Bone Modifying agents Jae Young Joung (Korea)
Sponsored Symposium 8 - Janssen Korea Ltd.
Prostate Cancer
Online Channel 2
Chairperson(s)
Cheol Kwak (Korea)
17:30-18:00
Treatment of mHSPC: The Paradigm Has Been Changing U Syn Ha (Korea)

October 17, Saturday

Sponsored Symposium 9 - MSD Korea LTD.
Online Channel 1
12:00-12:30
The Role of Anti-PD1 in BCG Unresponsive NMIBC: New Wave of Anti-PD1 in Management of Bladder Cancer Ho Kyung Seo (Korea)
Sponsored Symposium 10 - Hanmi Pharmaceutical Co.,Ltd.
Tamsulosin 0.4mg
Online Channel 2
12:00-12:30
Treatment Dose of Tamsulosin in LUTS/BPH; Unmet Needs and Real World Experience for Tamsulosin 0.4 mg Woong Jin Bae (Korea)
Sponsored Symposium 11 - MSD Korea LTD.
Online Channel 1
12:30-13:00
Optimal Treatment Using 5ARI for LUTS/BPH Patients Sung Kyu Hong (Korea)
Sponsored Symposium 12 - GSK (GlaxoSmithKline)
Online Channel 2
12:30-13:00
PSA and 5ARI Treatment : Clinical Implication in mLUTS/BPH Sung Yong Cho (Korea)
Sponsored Symposium 13 - JW Pharmaceutical
Online Channel 2
Chairperson(s)
Myung-Soo Choo (Korea)
15:00-15:30
Medical Treatment of LUTS/BPH: Focus on Alpha-blocker & New Formulation of 5-ARI Sang Jun Yoo (Korea)
Sponsored Symposium 14 - IpsenKorea Ltd.
GnRH treatment in prostate cancer
Online Channel 1
17:00-17:30
Up-to-date ADT Treatment Trend with Benefit of GnRHa, Triptorelin Chang Wook Jeong (Korea)